NCoR1 Mediates Papillomavirus E8^E2C Transcriptional Repression

ABSTRACT The papillomavirus E2 open reading frame encodes the full-length E2 protein as well as an alternatively spliced product called E8^E2C. E8^E2C has been best studied for the high-risk human papillomaviruses, where it has been shown to regulate viral genome levels and, like the full-length E2 protein, to repress transcription from the viral promoter that directs the expression of the viral E6 and E7 oncogenes. The repression function of E8^E2C is dependent on the 12-amino-acid N-terminal sequence from the E8 open reading frame (ORF). In order to understand the mechanism by which E8^E2C mediates transcriptional repression, we performed an unbiased proteomic analysis from which we identified six high-confidence candidate interacting proteins (HCIPs) for E8^E2C; the top two are NCoR1 and TBLR1. We established an interaction of E8^E2C with an NCoR1/HDAC3 complex and demonstrated that this interaction requires the wild-type E8 open reading frame. Small interfering RNA (siRNA) knockdown studies demonstrated the involvement of NCoR1/HDAC3 in the E8^E2C-dependent repression of the viral long control region (LCR) promoter. Additional genetic work confirmed that the papillomavirus E2 and E8^E2C proteins repress transcription through distinct mechanisms.

[1]  H. Okayama,et al.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells. , 1983, Molecular and cellular biology.

[2]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.

[3]  P. Howley,et al.  Bovine papillomavirus contains multiple transforming genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.

[5]  P. Howley,et al.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator , 1987, Cell.

[6]  L. Chow,et al.  Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. , 1989, Virology.

[7]  M. Botchan,et al.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs , 1989, Journal of virology.

[8]  P. Howley,et al.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Botchan,et al.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. , 1990, Science.

[10]  M. Stanley,et al.  Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. , 1990, Virology.

[11]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[12]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[13]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[14]  P. Howley,et al.  The papillomavirus E2 regulatory proteins. , 1991, The Journal of biological chemistry.

[15]  K. Münger,et al.  Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins , 1992, Journal of virology.

[16]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Howley,et al.  Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.

[18]  J. D. Benson,et al.  Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions , 1996, Journal of virology.

[19]  L. Chin,et al.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.

[20]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[21]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[22]  M. Yaniv,et al.  Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis , 1997, The EMBO journal.

[23]  C. Glass,et al.  A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.

[24]  A. McBride,et al.  Bovine Papillomavirus Type 1 Genomes and the E2 Transactivator Protein Are Closely Associated with Mitotic Chromatin , 1998, Journal of Virology.

[25]  E. Androphy,et al.  Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines , 1998, Journal of Virology.

[26]  C. Glass,et al.  SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. , 1998, Molecular cell.

[27]  I. Ilves,et al.  Long-Term Episomal Maintenance of Bovine Papillomavirus Type 1 Plasmids Is Determined by Attachment to Host Chromosomes, Which Is Mediated by the Viral E2 Protein and Its Binding Sites , 1999, Journal of Virology.

[28]  R. Shiekhattar,et al.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. , 2000, Genes & Development.

[29]  D. DiMaio,et al.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Qin,et al.  Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3 , 2000, The EMBO journal.

[31]  J. Torchia,et al.  A Novel Nuclear Receptor Corepressor Complex, N-CoR, Contains Components of the Mammalian SWI/SNF Complex and the Corepressor KAP-1* , 2000, The Journal of Biological Chemistry.

[32]  T. Iftner,et al.  The E8^E2C Protein, a Negative Regulator of Viral Transcription and Replication, Is Required for Extrachromosomal Maintenance of Human Papillomavirus Type 31 in Keratinocytes , 2000, Journal of Virology.

[33]  P. Howley,et al.  Mechanisms of Human Papillomavirus E2-Mediated Repression of Viral Oncogene Expression and Cervical Cancer Cell Growth Inhibition , 2000, Journal of Virology.

[34]  T. Iftner,et al.  The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31 , 2001, Journal of Virology.

[35]  Brian T Chait,et al.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. , 2002, Molecular cell.

[36]  T. Iftner,et al.  The Papillomavirus E8∧E2C Protein Represses DNA Replication from Extrachromosomal Origins , 2003, Molecular and Cellular Biology.

[37]  A. Hollenberg,et al.  Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. , 2003, Molecular endocrinology.

[38]  B. Aronow,et al.  Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jun Qin,et al.  Purification and functional characterization of the human N‐CoR complex: the roles of HDAC3, TBL1 and TBLR1 , 2003, The EMBO journal.

[40]  M. Privalsky,et al.  SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways* , 2004, Journal of Biological Chemistry.

[41]  C. Glass,et al.  A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.

[42]  P. Howley,et al.  Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes , 2004, Cell.

[43]  M. Duffy,et al.  Tumor-Associated Alterations in Caspase-14 Expression in Epithelial Malignancies , 2005, Clinical Cancer Research.

[44]  M. Lazar,et al.  The histone‐binding code of nuclear receptor co‐repressors matches the substrate specificity of histone deacetylase 3 , 2005, EMBO reports.

[45]  S. Balk,et al.  The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists* , 2005, Journal of Biological Chemistry.

[46]  M. Lazar,et al.  Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Botchan,et al.  Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. , 2006, Molecular cell.

[48]  S. Berger,et al.  A Feed-Forward Repression Mechanism Anchors the Sin3/Histone Deacetylase and N-CoR/SMRT Corepressors on Chromatin , 2006, Molecular and Cellular Biology.

[49]  Shwu‐Yuan Wu,et al.  Brd4 links chromatin targeting to HPV transcriptional silencing. , 2006, Genes & development.

[50]  D. C. Schultz,et al.  The KAP1 Corepressor Functions To Coordinate the Assembly of De Novo HP1-Demarcated Microenvironments of Heterochromatin Required for KRAB Zinc Finger Protein-Mediated Transcriptional Repression , 2006, Molecular and Cellular Biology.

[51]  T. Iftner,et al.  The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins , 2007, International journal of cancer.

[52]  B. Coulombe,et al.  Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. , 2007, Virology.

[53]  K. Wilson,et al.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture. , 2007, Biochemistry.

[54]  J. Gustafsson,et al.  Structural Insights into Corepressor Recognition by Antagonist-bound Estrogen Receptors* , 2007, Journal of Biological Chemistry.

[55]  P. Howley,et al.  Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins , 2007, Journal of Virology.

[56]  L. Turek,et al.  The E8∧E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes , 2008, Journal of Virology.

[57]  C. Glass,et al.  TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. , 2008, Molecular cell.

[58]  T. Iftner,et al.  Inhibition of Transcription and DNA Replication by the Papillomavirus E8⁁E2C Protein Is Mediated by Interaction with Corepressor Molecules , 2008, Journal of Virology.

[59]  S. Gygi,et al.  Defining the Human Deubiquitinating Enzyme Interaction Landscape , 2009, Cell.

[60]  Jennifer A. Smith,et al.  Brd4 Regulation of Papillomavirus Protein E2 Stability , 2009, Journal of Virology.

[61]  Jennifer A. Smith,et al.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. , 2009, Virology.

[62]  J. Archambault,et al.  Proteasomal Degradation of the Papillomavirus E2 Protein Is Inhibited by Overexpression of Bromodomain-Containing Protein 4 , 2009, Journal of Virology.

[63]  Mami Yamamoto,et al.  Neutral Cysteine Protease Bleomycin Hydrolase Is Essential for the Breakdown of Deiminated Filaggrin into Amino Acids*♦ , 2009, Journal of Biological Chemistry.

[64]  C. Chiang,et al.  Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability* , 2009, Journal of Biological Chemistry.

[65]  C. Glass,et al.  Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. , 2009, Molecular cell.

[66]  L. Shulman.  Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression , 2010 .